These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9425481)

  • 1. Topical levocabastine for the treatment of perennial allergic rhinitis.
    Elwany S; Bassiouny M
    J Laryngol Otol; 1997 Oct; 111(10):935-40. PubMed ID: 9425481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
    Janssens MM; Vanden Bussche G
    Clin Exp Allergy; 1991 May; 21 Suppl 2():29-36. PubMed ID: 1680536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of levocabastine on allergen-induced increase of nasal reactivity to histamine and cell influx.
    Pazdrak K; Górski P; Ruta U
    Allergy; 1993 Nov; 48(8):598-601. PubMed ID: 7906926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
    Dechant KL; Goa KL
    Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of levocabastine in perennial rhinitis].
    Pacor ML; Biasi D; Maleknia T; Carletto A; Lunardi C
    Clin Ter; 1996 Jun; 147(6):295-8. PubMed ID: 8925638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective H1 antagonist].
    Akiyoshi M; Shigeoka T; Torii S; Maki E; Enomoto S; Takahashi H; Hirano F
    Nihon Yakurigaku Zasshi; 2002 Mar; 119(3):175-84. PubMed ID: 11915520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levocabastine nasal spray significantly improves perennial allergic rhinitis: a single-blind placebo-controlled study.
    Okubo K; Uchida E; Nogami S
    Auris Nasus Larynx; 2010 Aug; 37(4):436-42. PubMed ID: 20138720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of topical levocabastine on allergic and non-allergic perennial rhinitis. A double-blind study, levocabastine vs. placebo, followed by an open, prospective, single-blind study on beclomethasone.
    van de Heyning PH; van Haesendonck J; Creten W; Rombaut N
    Allergy; 1988 Jul; 43(5):386-91. PubMed ID: 3046408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine.
    Borum S; Nielsen K; Bisgaard H; Mygind N
    Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S; McTavish D
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal levocabastine for the treatment of seasonal allergic rhinitis: a multicentre, double-blind, placebo-controlled trial.
    Dahl R; Pedersen B; Larsen B
    Rhinology; 1995 Sep; 33(3):121-5. PubMed ID: 8560160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of allergic rhinitis: focus on intranasal agents.
    Dushay ME; Johnson CE
    Pharmacotherapy; 1989; 9(6):338-50. PubMed ID: 2575739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levocabastine versus cetirizine for perennial allergic rhinitis in children].
    Arreguín Osuna L; García Caballero R; Montero Cortés MT; Ortiz Aldana I
    Rev Alerg Mex; 1998; 45(3):7-11. PubMed ID: 9718972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis.
    Bende M; Pipkorn U
    Allergy; 1987 Oct; 42(7):512-5. PubMed ID: 2891316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of levocabastine and furosemide pretreatment on hyperreactive response after nasal provocation with hypotonic aerosol in subjects with allergic rhinitis.
    Anzic SA; Dzepina D; Kalogjera L
    Eur Arch Otorhinolaryngol; 2007 Nov; 264(11):1309-14. PubMed ID: 17618447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P; Kaliner MA; Wheeler WJ
    Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of topical steroids on nasal nitric oxide production in children with perennial allergic rhinitis: a pilot study.
    Baraldi E; Azzolin NM; Carrà S; Dario C; Marchesini L; Zacchello F
    Respir Med; 1998 Mar; 92(3):558-61. PubMed ID: 9692122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N; Wober W; Rahlfs VW; Baehre M
    Arzneimittelforschung; 2001; 51(5):387-93. PubMed ID: 11413739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.